A red blood cell transfusion is a medical procedure that delivers donated red blood cells into your bloodstream through an intravenous (IV) line. It’s one of the most common hospital procedures, used to restore your body’s ability to carry oxygen when your red blood cell count or hemoglobin level drops too low. Each unit of transfused red blood cells raises your hemoglobin by roughly 1 g/dL, and the infusion typically takes about 1.5 to 2 hours per unit.
Why You Might Need a Transfusion
Red blood cells carry oxygen from your lungs to every tissue in your body. When you don’t have enough of them, your organs start running short on oxygen, a state called anemic hypoxia. This can happen for several reasons: major blood loss from surgery or trauma, chronic conditions like kidney disease or cancer that suppress red blood cell production, blood disorders like sickle cell disease or thalassemia, or chemotherapy that damages bone marrow.
The decision to transfuse isn’t based on a single number. Doctors weigh your hemoglobin level against your symptoms and medical history. That said, clear thresholds exist. A hemoglobin level at or below 6 g/dL is considered an absolute indication for transfusion regardless of other factors. Above 10 g/dL, transfusion almost never provides benefit. The gray zone falls between those numbers, where the decision depends on whether you have heart disease, active bleeding, or signs that your tissues aren’t getting enough oxygen, such as a racing heart, dizziness, or chest pain.
Restrictive vs. Liberal Transfusion Strategies
For decades, doctors debated how aggressively to transfuse. The 2023 AABB international guidelines, based on 45 randomized trials involving more than 20,000 adults, now recommend a restrictive approach for most hospitalized patients who are hemodynamically stable: consider transfusion when hemoglobin falls below 7 g/dL. This threshold applies broadly, including critically ill adults and children, and patients with blood cancers. Patients undergoing cardiac surgery may be transfused at 7.5 g/dL, and those having orthopedic surgery or living with cardiovascular disease at 8 g/dL. These restrictive thresholds perform just as well as more liberal strategies that transfuse at 9 to 10 g/dL, with the added benefit of conserving a limited blood supply and reducing exposure to potential complications.
How Blood Compatibility Is Determined
Before any transfusion, the blood bank runs a series of tests to make sure the donated red blood cells are safe for you. First, your blood is typed for ABO group (A, B, AB, or O) and Rh factor (positive or negative). Then an antibody screen checks whether your blood contains antibodies that could react against donor cells. Finally, a crossmatch test mixes a small sample of your blood with the donor’s blood. If your immune cells attack the donor cells, the crossmatch is positive and that unit is rejected. A negative crossmatch means the pair is compatible and the transfusion can proceed.
In emergencies where there’s no time for full testing, type O negative red blood cells are used as a universal donor product. Full compatibility testing catches up afterward.
What Happens During the Transfusion
A nurse inserts an IV line, usually in your arm, and connects a bag of packed red blood cells through tubing with a built-in filter. The infusion starts slowly for the first 15 minutes, which is when most serious reactions appear. If you tolerate it well, the rate increases. One unit generally finishes in 1.5 to 2 hours, though it can be slowed to a maximum of 4 hours for patients who are sensitive to fluid volume, such as those with heart failure.
Throughout the process, your vital signs are monitored at a minimum of three time points: before the transfusion begins, 15 minutes after it starts, and when it finishes. At each check, the nursing team records your blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature. Some hospitals check more frequently, adding assessments at 45 minutes and hourly intervals until completion.
Modified Red Blood Cell Products
Not all red blood cell units are the same. Some patients need specially processed blood. Leukoreduced red blood cells have had the white blood cells filtered out, which reduces the risk of febrile (fever) reactions, lowers the chance of transmitting certain viruses like cytomegalovirus (CMV), and helps prevent the immune system from developing antibodies against future transfusions. This is especially important for patients who receive transfusions frequently, such as those with thalassemia, and for people who may eventually need an organ or bone marrow transplant.
Irradiated red blood cells are treated with radiation to disable any remaining donor white blood cells, preventing them from attacking the recipient’s body. This is reserved for patients with severely weakened immune systems, including premature infants, certain cancer patients, and bone marrow transplant recipients. Washed red blood cells have had the surrounding plasma proteins removed, which helps patients who have allergic reactions to standard transfusions.
Risks and Complications
Most transfusions are uneventful, but reactions do occur. The most feared is an acute hemolytic reaction, where your immune system destroys the transfused red blood cells. This typically happens within the first hour and presents as a triad of fever, flank pain, and red or brown urine. Other early warning signs include chills, burning at the IV site, chest tightness, nausea, and a drop in blood pressure. If any of these appear, the transfusion is stopped immediately.
Two lung-related complications deserve attention. Transfusion-associated circulatory overload (TACO) happens when the added fluid volume overwhelms the heart, causing fluid to back up into the lungs. It’s more common in older adults and people with existing heart conditions. Transfusion-related acute lung injury (TRALI) is a different process where donor antibodies trigger inflammation in the lungs, causing sudden breathing difficulty without fluid overload. Both cause shortness of breath and low oxygen levels within six hours of transfusion, but they require different treatments. TRALI was historically seen in about 0.1% of transfused patients, though improved donor screening has dropped that rate dramatically to roughly 0.001%.
Milder reactions are more common. Febrile reactions cause a temporary fever and chills. Allergic reactions produce hives or itching. Both are usually manageable and don’t prevent future transfusions.
How Results Are Measured
After the transfusion, a blood test confirms whether your hemoglobin rose as expected. The standard expectation is an increase of about 1 g/dL per unit transfused, though the actual rise depends on your starting level. Research shows that patients with more severe anemia get a proportionally larger bump from each unit. This means that in many cases, a single unit is enough to reach the target hemoglobin, and a second unit may not be necessary.
Iron Overload From Repeated Transfusions
Each unit of red blood cells delivers a significant dose of iron. Your body has no natural mechanism for excreting excess iron, so patients who receive transfusions regularly, such as those with sickle cell disease, thalassemia, or myelodysplastic syndromes, gradually accumulate iron in their organs. Over time, this iron overload can damage the liver, heart, and hormone-producing glands. Symptoms develop slowly and may include joint pain, fatigue, abdominal discomfort, and skin changes.
Patients on chronic transfusion programs have their iron levels monitored through blood tests and sometimes liver or cardiac imaging. When iron stores climb too high, iron chelation therapy is used to help the body eliminate the excess. The goal is to balance the life-sustaining benefits of regular transfusions against the long-term organ damage that unchecked iron buildup can cause.